CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Management of Discontinued Treatment for Tuberculosis: Guidelines

Last updated: September 26, 2020
Project Number: RB1516-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What are the evidence-based guidelines regarding the management of people with latent tuberculosis infection who discontinue their treatment prior to completion?
  2. What are the evidence-based guidelines regarding the management of people with active tuberculosis disease who discontinue their treatment prior to completion?

Key Message

No evidence-based guidelines were found regarding the management of people with latent or active tuberculosis who discontinue their treatment prior to completion.